notice, FDA opened a public docket to solicit input and comments from interested stakeholders, including racial and ethnic minority, underrepresented, and underserved populations on the Office of Minority Health and Health Equity Strategic Priorities (OMHHE). The Office of Minority Health and Health Equity (OMHHE) Mission: Advance health equity and women’s health issues across the nation through CDC’s science and programs, and increase CDC’s capacity to leverage its diverse workforce and engage stakeholders toward this end. Office of Minority Health and Health Equity (OMHHE) Strategic Priorities Public Docket 02/28/2020 The National Health Council (NHC) appreciates the opportunity to provide comments as the Food and Drug Administration’s (FDA’s) establishes its Office of Minority Health and Health Equity (OMHHE) Strategic Priorities public docket. Office of Minority Health Resource Center Toll Free: 1-800-444-6472 / Fax: 301-251-2160 Email: info@minorityhealth.hhs.gov Stay Connected The FDA Office of Minority Health and Health Equity (OMHHE) serves to promote and protect the health of diverse populations through research and communication of science that addresses health disparities. FDA is reopening the comment period to update comments and to receive any new information. Mission. FDA Office of Minority Health and Health Equity April 28, 2020 Reopening Comment Period: FDA OMHHE is Seeking Public Feedback on Strategic Priorities The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice, published in the Federal Register of January 3, 2020. February 28, 2020, 333 Cedar St. in the Harkness Auditorium. The Office of Minority Health Resource Center online library catalog provides access to the nation’s largest repository of information dedicated to the health of minority populations within the United States and its territories. The Innovation and Diversity Summit: Patient-centered Approaches to Care and Research, a collaboration of Yale School of Medicine and our partners at the FDA Office of Minority Health and Health Equity and the YCCI Cultural Ambassadors for Clinical Research, will focus on raising … We aim to: increase the amount of clinical trial data available on … The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled ``Office of Minority Health and Health Equity Public Meeting on Strategies to Improve Health Equity Amidst the Opioid Crisis.'' AGENDA. Click here to register. The FDA Office of Minority Health and Health Equity (OMHHE) serves to promote and protect the health of diverse populations through research and communication of science that addresses health … “The FDA, including the Office of Minority Health and Health Equity (OMHHE), promotes and protects the health of diverse populations and strives for health equity for all, including those who experience disparities related to race and ethnicity.” The agency is working to reduce disparities and encourage diversity in clinical trials.